We are live on
!
Find out more
ASA
Armstrong Shaw Associates Portfolio holdings
AUM
$95.2M
1-Year Est. Return
23.67%
This Fund
S&P 500
This Quarter
Est. Return
+9.2%
1 Year Est. Return
+23.67%
3 Year Est. Return
+51.2%
5 Year Est. Return
+82.8%
10 Year Est. Return
+225.63%
AUM
$115M
AUM Growth
+$5.73M
(+5.2%)
Cap. Flow
-$3.72M
Cap. Flow
% of AUM
-3.24%
Top 10 Holdings %
Top 10 Hldgs %
56.36%
Holding
44
New
1
Increased
–
Reduced
28
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$197K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$687K |
| 2 |
Apple
AAPL
|
+$444K |
| 3 |
Intercontinental Exchange
ICE
|
+$285K |
| 4 |
Alibaba
BABA
|
+$264K |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$231K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.88% |
| 2 | Technology | 20.68% |
| 3 | Healthcare | 15.4% |
| 4 | Consumer Discretionary | 13.87% |
| 5 | Communication Services | 9.64% |
Similar funds
AEPLI
GG
VI
TAM
WCM
QT
OC
KC
Armstrong Shaw Associates's Q2 2021 Portfolio in Review
As of Q2 2021, Armstrong Shaw Associates held 44 positions worth $115M, up 5.2% from $109M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Armstrong Shaw Associates withdrew a net $3.72M in Q2 2021, reducing 28 holdings. Its largest reduction was Microsoft, cutting an estimated $687K.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Armstrong Shaw Associates opened a new position in Gilead Sciences worth $203K.
- Armstrong Shaw Associates's largest Q2 2021 buy was Gilead Sciences: 2,950 shares worth $203K.
- Armstrong Shaw Associates's biggest Q2 2021 reduction was Microsoft, cutting an estimated $687K.
- Armstrong Shaw Associates's ten largest holdings make up 56% of its $115M portfolio in Q2 2021.
- Armstrong Shaw Associates opened 1 new position and closed 0 in Q2 2021.
- Armstrong Shaw Associates's portfolio value rose 5.2% quarter-over-quarter to $115M.
Based on Armstrong Shaw Associates's 13F filing for Q2 2021, filed 5 Aug 2021.